Business Description
Evelo Biosciences Inc
NAICS : 325411
SIC : 2833
ISIN : US2997341035
Description
Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.51 | |||||
| Equity-to-Asset | -1.3 | |||||
| Debt-to-Equity | -1.27 | |||||
| Debt-to-EBITDA | -0.46 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 22.6 | |||||
| 3-Year EPS without NRI Growth Rate | 21.2 | |||||
| 3-Year FCF Growth Rate | 20.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.65 | |||||
| 9-Day RSI | 55.94 | |||||
| 14-Day RSI | 51.7 | |||||
| 6-1 Month Momentum % | -91.8 | |||||
| 12-1 Month Momentum % | -97.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.48 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -51 | |||||
| Shareholder Yield % | 441.76 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -175.81 | |||||
| ROIC % | -182.52 | |||||
| ROC (Joel Greenblatt) % | -856.93 | |||||
| ROCE % | -897.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.23 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-FCF | -0.24 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -7862.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EVLO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evelo Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -14 | ||
| Beta | 1.95 | ||
| Volatility % | 273.23 | ||
| 14-Day RSI | 51.7 | ||
| 14-Day ATR ($) | 0.010147 | ||
| 20-Day SMA ($) | 0.044965 | ||
| 12-1 Month Momentum % | -97.5 | ||
| 52-Week Range ($) | 0.028 - 13.93 | ||
| Shares Outstanding (Mil) | 18.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Evelo Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Evelo Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Evelo Biosciences Inc Frequently Asked Questions
What is Evelo Biosciences Inc(EVLO)'s stock price today?
The current price of EVLO is $0.05. The 52 week high of EVLO is $13.93 and 52 week low is $0.03.
When is next earnings date of Evelo Biosciences Inc(EVLO)?
The next earnings date of Evelo Biosciences Inc(EVLO) is 2024-05-31 Est..
Does Evelo Biosciences Inc(EVLO) pay dividends? If so, how much?
Evelo Biosciences Inc(EVLO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers